PharmiWeb.com - Global Pharma News & Resources
04-May-2021

Small Molecules to Hold around 90% Share in Active Pharmaceutical Ingredients Market

Prevalence of chronic diseases is constantly on the rise across the world. This is leading to a major health burden on governments and the society in general. Out of these, cardiovascular diseases make up around half of the total deaths caused by chronic diseases. According to the World Health Organization, in 2016, ischemic heart disease and stroke accounted for around 27% of total deaths, worldwide. Chronic obstructive pulmonary disease was the third most cause of death in the same years. These non-communicable diseases were major causes of deaths globally, ranging from 37% in lower economies and 88% in countries with high income.

FMI projects the antibiotics active pharmaceutical ingredient API market to record a steady CAGR of 3.1% through 2030. Demand for API is anticipated to continue surging because the governments are diverting a greater portion of their revenue towards extensive research

Collaboration and exchange of new and innovative models for reimbursing new antibiotics is an emerging trend among leading manufacturers.” says the FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-13025

API Market – Important Highlights

  • According to product type, Penicillin antibiotics dominate the market
  • Pharmaceutical firms have emerged as the leading end users of antibiotic APIs
  • Sales in China will account for about 22 percent of overall global demand over the forecast period
  • Us is anticipated to remain as one of the most lucrative markets.

API Market – Drivers

  • The higher prevalence of bacterial diseases is boosting the growth of the market
  • Market Players are Focusing on R&D and Innovations which is driving the growth of the market
  • Favorable government policies and investments in the healthcare sector are anticipated to contribute to the growth of the market

API Market – Restraints

  • A lack of knowledge of antibiotic use and the use of antibiotics in non-serious infections can cause adverse side effects
  • High medical costs are anticipated to remain a market restraint during the forecast era

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-13025

COVID-19 Impact on API Market

After the Covid-19 outbreak, demand for APIs decreased. The pandemic has contributed to a decline in the influx of patients to hospitals and doctor’s chambers. When the focus of the health services shifts to the emergency care of COVID-19, treatment for other illnesses and accidents is de-prioritized. However, this is projected to have a temporary impact and the sector is supposed to have a rebound with the stabilization of the economy.

Competitive Landscape

The API market players are leaning towards the expansion of the production facilities besides opting for strategic collaborations to attain a competitive edge. For example, in October 2017, CordenPharma acquired an API site from Pfizer, Inc., formerly part of the Hospira Boulder (Colorado) high containment API to shape its place in the leading competitive market.

Some of the prominent players listed in the global API market are Sandoz International GmbH, Centrient Pharmaceuticals, CordenPharma International, ACS Dobfar spa, Dorra Pharmaceutical Technology Co. Ltd., Daewoong Pharmaceutical co. ltd., Parabolic Drugs Ltd.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/13025

Table Of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation /Development Trends

3.3. COVID19 Crisis Analysis

3.3.1. COVID19 and Impact Analysis

3.3.2. 2020 Market Scenario

3.3.3. Recovery Scenario- Short term, Midterm and Long Term Impact

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global GDP Growth Outlook

4.1.2. Global Healthcare Expenditure Outlook

4.2. Forecast Factors – Relevance & Impact

4.2.1. Research and Developmental Activities

4.2.2. Product Formulation Advancement

4.2.3. Key Players Historical Growth

4.2.4. Market Consolidation Activities

4.2.5. Growing Investment by Key Players in Product Development

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity Analysis

5. Market Context

5.1. Product USPs/ Features

5.2. Product Adoption / Usage Analysis

5.3. Regulatory Scenario

5.4. Supply-Chain Analysis

5.5. Consumption, By API Type (in Tons per Annum)

5.6. Pricing Analysis, BY API Type

6. Global Antibiotics API Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Absolute $ Opportunity Analysis

Download Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-13025

About the Study

The study offers readers a comprehensive assessment of the API market. Global, regional, and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights based on API type(penicillin antibiotics, cephalosporins, carbapenem antibiotics), the end-user( pharmaceutical companies, contract manufacturing organizations (CMOS), contract development & manufacturing organizations (CDMOs)) and across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

Explore FMI’s Coverage of the healthcare Industry

Pharmaceutical intermediates market: Get insights on the pharmaceutical intermediates market through FMI’s report covering detailed quantitative and qualitative analysis for the projection period 2020-2030

localized temperature therapy products market: FMI’s exhaustive study on the localized temperature therapy products market covers the latest trends, innovations, key players, and popular strategies for the period 2020-2030.

Compression therapy market: Obtain detailed analysis on the compression therapy

market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2020-2030.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/antibiotics-active-pharmaceutical-ingredient-api-market

Press Release Source: https://www.futuremarketinsights.com/press-release/antibiotics-active-pharmaceutical-ingredient-api-market

Editor Details

Last Updated: 04-May-2021